Lyme disease presenting as chronic fatigue syndrome

Journal of Chronic Fatigue Syndrome

Volumn 13, Issue 4, 2006, Pages 67-75

  Shor, Samuel ^a,b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

CFS; Chronic fatigue syndrome; Chronic Lyme disease; Fatigue; Lyme disease

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; COGNITIVE DEFECT; DYSAUTONOMIA; FATIGUE; FIBROMYALGIA; HUMAN; INFESTATION; LYME DISEASE; MALE; RISK; SLEEP DISORDER; TICK;

EID: 35948972822     PISSN: 10573321     EISSN: 15470660     Source Type: Journal    
DOI: 10.1300/J092v13n04_06     Document Type: Article

References (52)

1. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE et al. Chronic Fatigue Syndrome: A working case definition. Ann Intern Med 1988; 108: 387-389.
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A et al. The Chronic Fatigue Syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-960.
3. Shor S. Pathogenesis of chronic fatigue syndrome, a multisystem hypothesis. J of Chronic Fatigue Syndrome 2003; 11(3): 51-68.
4. Stricker RB et al. Letter to the editor re Inaccurate information about Lyme Disease on the internet. The Pediatric Infectious Disease Journal 2005; 24:577-578.
5. Feder HM Jr. Differences are voiced by two Lyme camps at a Connecticut public hearing on insurance coverage of Lyme disease. Pediatrics 2000; 105(4pt 1): 855-857.
6. Wormser GP, Nadelman RB, Dattwyler RJ et al. Practice guidelines for the treatment of Lyme disease: The Infectious Diseases Society of America. Clin Infect Dis 2000; 105(4pt 1): 855-857.
7. The ILADS Working Group. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti-Infect Ther 2004; 2(suppl): S1-S13.
8. Shah J. Igenex publication July 6, 2005.
9. Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arhtritis Rheum 1977; 20: 7-17.
10. Barbour AG. Linear DNA of Borrelia species and antigenic variation. Trends Microbiol 1993; 1: 236-239.
11. Postic D, Assous MV, Grimont PA, Baranton G. Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphisms of rrf(5S)-rrl (23S) inter-genic spacer amplicons. Int J Syst Bacteriol 1994; 44: 743-752.
12. Steere AC. The Borellia burgdoerferi sensu lato is transmitted by Ixodes dammini and other related ixodid ticks. Lyme disease. N Engl J Med 1989; 321: 586-596.
13. Steere AC, Grodzicki RL, Kornblatt AN et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983; 308: 733-740.
14. Steere AC, Malawista SE, Hardin JA et al. Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med 1977; 86: 685-698.
15. Feder HM Jr, Gerber M, Krause PJ. Early Lyme disease: A flu-like illness without erythema migrans. Pediatrics 1993; 91: 456-459.
16. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990; 323: 1438-1444.
17. Rawlings JA, Fournier PV, Teltow GJ. Isolation of Borrelia burgdorferi from patients in Texas. J Clin Microbiol 1987; 25(7): 1148-1150.
18. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996; 34(1): 1-9.
19. Aguero-Rosenfeld ME, Nowakoski J, McKenna DF, Carbonaro CA, Wormser GP. Sero-diagnosis in early Lyme disease. J Clin Microbiol 1993; 31(12), 3090-3095.
20. Donta ST. Tetracycline therapy of chronic Lyme Disease. Clin Infect Dis 1997; 25: S52-56.
21. Donta ST. Treatment of chronic Lyme disease with macrolide antibiotics. In: Program and abstracts of the VIIIth International Conference on Lyme Borreliosis; June 20-24, 1999; Munich, Germany. Abstract P. 193.
22. Donta ST. Late and chronic Lyme disease. Med Clin North Am 2002; 86(2): 341-349.
23. National Institutes of Allergy and Infectious Diseases (National Institute of Health) profile, fiscal year 2001 HYPERLINK "http://www.niaid. nih.gov/publications/NIAIDProfile" (accessed January 2006).
24. Donta S. Late and Chronic Lyme Disease: Symptom Overlap with Chronic Fatigue Syndrome & Fibromyalgia. ImmuneSupport.com Treatment & Research Information 5/15/02.
25. Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Disease 1992; 166: 440-444.
26. Klempner MS, Noring R, Rogers RA. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J Infect Disease 1993; 167: 1074-81.
27. Haupl T, Hahn G, Rittig M, Krause A, Schoerner C, et al. Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme Borreliosis. Arthritis Rheum 1993; 36: 1621-1626.
28. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci USA 1995; 92: 2909-2913.
29. De Silva AM, Telford SR III, Brunet LR, Barthold SW, Fikring E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 1996; 183: 271-275.
30. Henderson IR, Owen P, Nataro JP. Molecular switches - the ON and OFF of bacterial phase variation. Mol Microbiol 1999; 33(5): 919-932.
31. Embers ME, Ramamoorthy R, Philipp MT. Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease. Microbes and Infection 2004; 6: 312-318.
32. Schutzer SE, Coyle PK, Belman AL et al. Sequestration of antibody to Borrelia burgdorferi in immune complexes in sero-negative Lyme disease. Lancet 1990; 335(8685): 312-315.
33. Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole. Int Microbiol 2004 Jun; 7(2): 139-142.
34. Brorson O, Brorson SH. Transformation of cystic forms of Borrelia burgdorferi to normal mobile spirochetes. Infection 1997; 25: 240-246.
35. Bruck DK, Talbot ML, Cluss RG, Boothby JT. Ultrastuctural characterization of the stages of spheroplast preparation of Borrelia burgdorferi. J Microbiol Methods 1995; 23: 219-228.
36. Murgia R, Piazzetta C, Cinco M. Cystic forms of Borrelia burgdorferi sensu lato: Induction, development and the role of RpoS. Wien Klin Wochenschr 2002; 114(13-14): 574-579.
37. Gruntar I et al. Conversion of Borrelia garinii cystic forms to motile spirochetes in vivo. APMIS 2001; 109(5): 383-388.
38. Bayer ME, Zhang L, Bayer MH. Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases. Infection 1996; 24; 347-353.
39. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330: 229-334.
40. Preac-Mursic V, Weber K, Pfister HW, Gross WB, Baumann A, Prokop J. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 1989; 17: 7-11.
41. Battafarano DF, Combs JA, Enzenauer RJ, and Fitzpatrick JE. Chronic septic arthritis caused by Borrelia burgdorferi. Clinical Orthopaedics and Related Research Number 1993; 297: 238-241.
42. Schmidli J, Hunziker T, Moesli P, Schaad UB. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. The Journal of Infectious Diseases 1988 Oct; 158(4): 905-906.
43. Hudson BJ, Stewart M, Lennox VA, Fukunaga M, Yabuki M, Macorison H, Kitchener-Smith J. Culture-positive Lyme borreliosis. MJA 1998 May 18; 168: 500-502.
44. Baker JA. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day post infection period. J Clin Microbiol 2000; 38(6): 2191-2199.
45. Thompson C, Spielman A, and Krause PJ. Co-infecting deer-associated zoonoses: Lyme disease, babebiosis, and ehrlichiosis. CID 2001; 33(1 September): 676-685.
46. Mather TN, Telford SR, Moore SI, Speilman A. Borrelia burgdorferi and Babesia microti: Efficiency of transmission from reservoirs to vector ticks (Ixodes dammini). Exp Parasitol 1990; 70: 55-61.
47. Bosler EM, Coleman JL, Benach JL et al. Natural distribution of the Ixodes dammini spirochetes. Science 1983; 220-321.
48. Eskow E, Rao R-VS, Mordechai E. Concurrent infection of the central nervous system by Borrelia burgdorferi and Bartonella henselae evidence for a novel tickborne disease complex. Arch Neurol 2001; 58: 1357-1363.
49. Podsiadly E, Chmielewski T, Tylewska-Wierzbanowska S. Bartonella henselae and Borellia burgdorferi. Infections of the central nervous system. Ann NY Acad Sci 2003; 990: 404-406.
50. Krause PJ, Telford S, Spielman A et al. Concurrent Lyme disease and babesiosis: Evidence for increased severity and duration of illness. JAMA 1996; 275: 1657-1660.
51. Marcus LC, Steere AC, Duray PH et al. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis: Demonstration of spirochetes in the myocardium. Ann Intern Med 1985; 103: 374-376.
52. Thompson C, Krause P, Telford S et al. Increased severity of Lyme disease illness due to concurrent babesiosis and ehrlichiosis (abstract 1757). In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology 2000; 500.